ASTH
Price
$22.03
Change
+$0.65 (+3.04%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
1.07B
92 days until earnings call
Intraday BUY SELL Signals
UHS
Price
$227.79
Change
-$1.05 (-0.46%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
14.24B
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASTH vs UHS

Header iconASTH vs UHS Comparison
Open Charts ASTH vs UHSBanner chart's image
Astrana Health
Price$22.03
Change+$0.65 (+3.04%)
Volume$17.26K
Capitalization1.07B
Universal Health Services
Price$227.79
Change-$1.05 (-0.46%)
Volume$4.58K
Capitalization14.24B
ASTH vs UHS Comparison Chart in %
ASTH
Daily Signal:
Gain/Loss:
UHS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ASTH vs. UHS commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Hold and UHS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ASTH: $21.35 vs. UHS: $228.84)
Brand notoriety: ASTH and UHS are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ASTH: 147% vs. UHS: 106%
Market capitalization -- ASTH: $1.1B vs. UHS: $14.24B
ASTH [@Hospital/Nursing Management] is valued at $1.1B. UHS’s [@Hospital/Nursing Management] market capitalization is $14.24B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $109.77B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 1 FA rating(s) are green whileUHS’s FA Score has 3 green FA rating(s).

  • ASTH’s FA Score: 1 green, 4 red.
  • UHS’s FA Score: 3 green, 2 red.
According to our system of comparison, UHS is a better buy in the long-term than ASTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 6 TA indicator(s) are bullish while UHS’s TA Score has 3 bullish TA indicator(s).

  • ASTH’s TA Score: 6 bullish, 5 bearish.
  • UHS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ASTH is a better buy in the short-term than UHS.

Price Growth

ASTH (@Hospital/Nursing Management) experienced а -10.29% price change this week, while UHS (@Hospital/Nursing Management) price change was +1.97% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -2.22%. For the same industry, the average monthly price growth was -6.66%, and the average quarterly price growth was +2.60%.

Reported Earning Dates

ASTH is expected to report earnings on Feb 19, 2026.

UHS is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Hospital/Nursing Management (-2.22% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UHS($14.2B) has a higher market cap than ASTH($1.07B). ASTH has higher P/E ratio than UHS: ASTH (112.37) vs UHS (10.85). UHS YTD gains are higher at: 27.965 vs. ASTH (-32.287). UHS has higher annual earnings (EBITDA): 2.43B vs. ASTH (112M). ASTH has more cash in the bank: 342M vs. UHS (138M). ASTH has less debt than UHS: ASTH (448M) vs UHS (5.01B). UHS has higher revenues than ASTH: UHS (16.5B) vs ASTH (2.42B).
ASTHUHSASTH / UHS
Capitalization1.07B14.2B8%
EBITDA112M2.43B5%
Gain YTD-32.28727.965-115%
P/E Ratio112.3710.851,036%
Revenue2.42B16.5B15%
Total Cash342M138M248%
Total Debt448M5.01B9%
FUNDAMENTALS RATINGS
ASTH vs UHS: Fundamental Ratings
ASTH
UHS
OUTLOOK RATING
1..100
7186
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
22
Undervalued
PROFIT vs RISK RATING
1..100
9633
SMR RATING
1..100
8447
PRICE GROWTH RATING
1..100
9116
P/E GROWTH RATING
1..100
464
SEASONALITY SCORE
1..100
9034

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UHS's Valuation (22) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (83) in the null industry. This means that UHS’s stock grew somewhat faster than ASTH’s over the last 12 months.

UHS's Profit vs Risk Rating (33) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (96) in the null industry. This means that UHS’s stock grew somewhat faster than ASTH’s over the last 12 months.

UHS's SMR Rating (47) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (84) in the null industry. This means that UHS’s stock grew somewhat faster than ASTH’s over the last 12 months.

UHS's Price Growth Rating (16) in the Hospital Or Nursing Management industry is significantly better than the same rating for ASTH (91) in the null industry. This means that UHS’s stock grew significantly faster than ASTH’s over the last 12 months.

ASTH's P/E Growth Rating (4) in the null industry is somewhat better than the same rating for UHS (64) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew somewhat faster than UHS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHUHS
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
46%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 2 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 6 days ago
65%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signal:
Gain/Loss:
UHS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PJP104.141.12
+1.09%
Invesco Pharmaceuticals ETF
EKG18.320.12
+0.66%
First Trust Nasdaq Lux Dgtl Hlth SoluETF
GLOV56.35-0.06
-0.11%
Goldman Sachs ActBt Wld Lw Vl Ps Eq ETF
TDI37.17-0.39
-1.03%
Touchstone Dynamic International ETF
TEC27.30-0.31
-1.12%
Harbor Transformative Technologies ETF

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
+1.52%
ACHC - ASTH
51%
Loosely correlated
-4.09%
DCGO - ASTH
38%
Loosely correlated
-3.40%
UHS - ASTH
30%
Poorly correlated
+1.03%
ENSG - ASTH
30%
Poorly correlated
+0.50%
PNTG - ASTH
29%
Poorly correlated
+2.72%
More